{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:34:18Z","timestamp":1768293258216,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpagonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric and Adolescent Gynecology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.jpag.2011.10.010","type":"journal-article","created":{"date-parts":[[2011,12,30]],"date-time":"2011-12-30T08:46:43Z","timestamp":1325234803000},"page":"138-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Can von Willebrand Disease Be Investigated on Combined Hormonal Contraceptives?"],"prefix":"10.1016","volume":"26","author":[{"given":"Tania","family":"Dumont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sari","family":"Kives","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpag.2011.10.010_bib1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2516.2007.01496.x","article-title":"The prevalence of disorders of haemostasis in adolescents with menorrhagia referred to a haemophilia treatment centre","volume":"13","author":"Mikhail","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.jpag.2011.10.010_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.jpag.2011.10.010_bib3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0037-1613992","article-title":"Impact, diagnosis and treatment of von Willebrand disease","volume":"84","author":"Sadler","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2011.10.010_bib4","first-page":"631","article-title":"Effect of two low-dose contraceptives on circulating components of the coagulation and fibrinolytic systems","volume":"109","author":"Gevers Leuven","year":"1987","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jpag.2011.10.010_bib5","first-page":"725","article-title":"Influence of triphasic oral contraceptives on blood rheology and hemostatic and metabolic patterns in young women. Results of a three-year study","volume":"37","author":"Solerte","year":"1992","journal-title":"J Reprod Med"},{"key":"10.1016\/j.jpag.2011.10.010_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<175::AID-AJH1>3.0.CO;2-X","article-title":"Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives","volume":"60","author":"Harris","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpag.2011.10.010_bib7","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1055\/s-0037-1614855","article-title":"Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive","volume":"82","author":"Kadir","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2011.10.010_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/107602969900500112","article-title":"Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestoden or levonorgestrel","volume":"5","author":"Prasad","year":"1999","journal-title":"Clin Appl Thrombosis\/Hemostasis"},{"key":"10.1016\/j.jpag.2011.10.010_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1538-7836.2005.01690.x","article-title":"Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response","volume":"4","author":"van Rooijen","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"2 Pt 1","key":"10.1016\/j.jpag.2011.10.010_bib10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/AOG.0b013e3181626d1b","article-title":"Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial","volume":"111","author":"Johnson","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2011.10.010_bib11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1055\/s-2006-949665","article-title":"Women and von Willebrand disease: controversies in diagnosis and management","volume":"32","author":"Kadir","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"Supp 1","key":"10.1016\/j.jpag.2011.10.010_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1538-7836.2007.02494.x","article-title":"Menorrhagia associated with laboratory abnormalities of hemostasis: epidemiological, diagnostic and therapeutic aspects","volume":"5","author":"Kouides","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpag.2011.10.010_bib13","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0015-0282(02)04285-1","article-title":"Effects of vaginally administered high\u00a0estradiol doses on hormonal pharmacokinetics and hemostasis in postmenopausal women","volume":"78","author":"Hall","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2011.10.010_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0002-9378(90)90594-W","article-title":"Hemostasis profile in women taking low-dose oral contraceptives","volume":"163","author":"David","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jpag.2011.10.010_bib15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.CIR.100.7.717","article-title":"Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen\/Progestin Interventions (PEPI) Study","volume":"100","author":"Cushman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jpag.2011.10.010_bib16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.fertnstert.2005.01.131","article-title":"Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women","volume":"84","author":"Osmana\u011fao\u011flu","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2011.10.010_bib17","first-page":"237","article-title":"Hormone replacement therapy in healthy postmenopausal women: a randomized, placebo-controlled study of effects on coagulation and fibrinolytic factors","volume":"249","author":"Gotts\u00e4ter","year":"2001","journal-title":"J Intern Med"},{"key":"10.1016\/j.jpag.2011.10.010_bib18","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/ndt\/15.11.1835","article-title":"Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients","volume":"15","author":"Park","year":"2000","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.jpag.2011.10.010_bib19","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/00365510410002995","article-title":"Circulating concentrations of hemostatic factors and two \u201csteroid sensitive proteins\u201d during oral hormone replacement therapy in women with coronary heart disease","volume":"64","author":"Pripp","year":"2004","journal-title":"Scand J Clin Lab Inv"},{"key":"10.1016\/j.jpag.2011.10.010_bib20","first-page":"80","article-title":"Short-term oral administration effects of Danazol and Estrogens on the von Willebrand Factor","volume":"40","author":"Fukuoka","year":"1995","journal-title":"Jpn J Fertil Steril"},{"key":"10.1016\/j.jpag.2011.10.010_bib21","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0735-1097(02)02565-2","article-title":"Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women","volume":"40","author":"Rabbani","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jpag.2011.10.010_bib22","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"}],"container-title":["Journal of Pediatric and Adolescent Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318811004207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318811004207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:40:14Z","timestamp":1761054014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083318811004207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1083318811004207"],"URL":"https:\/\/doi.org\/10.1016\/j.jpag.2011.10.010","relation":{},"ISSN":["1083-3188"],"issn-type":[{"value":"1083-3188","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can von Willebrand Disease Be Investigated on Combined Hormonal Contraceptives?","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric and Adolescent Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpag.2011.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}